| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
See Remarks
1 company
Henn Matthew R is a See Remarks at Seres Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 10 sells.
Estimated insider holdings value: $36K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 15, 2025 | MCRB Seres Therapeutics, Inc. | See Remarks | Sale+OE | 1,257 | $17.30 | $21,746.10 | -14.3% | -49.2% | - | |
| Aug 18, 2025 | MCRB Seres Therapeutics, Inc. | See Remarks | Sale+OE | 73 | $16.65 | $1,215.45 | -1.6% | +22.3% | - | |
| May 16, 2025 | MCRB Seres Therapeutics, Inc. | See Remarks | Sale+OE | 77 | $7.28 | $560.56 | -1.7% | +126.0% | +2.4% | |
| Feb 18, 2025 | MCRB Seres Therapeutics, Inc. | See Remarks | Sale+OE | 3,953 | $0.81 | $3,203.51 | -4.5% | -52.0% | -50.5% | |
| Nov 18, 2024 | MCRB Seres Therapeutics, Inc. | See Remarks | Sale+OE | 927 | $0.54 | $501.23 | -1.2% | +43.6% | +113.4% | |
| Oct 28, 2024 | MCRB Seres Therapeutics, Inc. | See Remarks | Sale+OE | 3,984 | $0.69 | $2,749.36 | -5.0% | +20.2% | +22.6% | |
| Aug 16, 2024 | MCRB Seres Therapeutics, Inc. | See Remarks | Sale+OE | 923 | $0.84 | $775.32 | -1.4% | -32.7% | -5.1% | |
| May 15, 2024 | MCRB Seres Therapeutics, Inc. | See Remarks | Sale+OE | 891 | $0.94 | $837.54 | -1.3% | -13.6% | -61.3% | |
| Feb 16, 2024 | MCRB Seres Therapeutics, Inc. | See Remarks | Sale+OE | 4,170 | $1.08 | $4,503.60 | -6.2% | -12.0% | -20.7% | |
| Oct 30, 2023 | MCRB Seres Therapeutics, Inc. | See Remarks | Sale+OE | 3,886 | $1.35 | $5,246.10 | -6.5% | -13.8% | -46.8% |